30/11/2009

H1N1 Evolution Outpacing Vaccine and Host Defenses. -- (Recombinomics)

 

The above data reinforced concerns that the changes at position 225 were becoming more prevalent, especially in samples collected from affected organs of fatal cases......

However, WHO has yet to address this result.  The "low reactor" status was quietly added to the characterization sheet at GISAID and there has been little comment in the mainstream media, other than a sentence in the New York Times on Friday......

Comment form WHO and other agencies, including Mill Hill and the CDC, who were conducting testing of the Ukrainian samples, is long overdue......

 

H1N1 Evolution Outpacing Vaccine and Host Defenses

18:23 Écrit par Dr MSFV | Lien permanent | Commentaires (0) |  Facebook |

Les commentaires sont fermés.